The tests conducted with the prototype vaccine RTS, S / AS02D malaria carried out by a Spaniard in Mozambique have shown the ability of this vaccine to immunize children under one year against the disease.

The study, which is in its second phase, is done by scientists at the Hospital Clinic in Barcelona and the Ministry of Health of Mozambique through the Center for Research in Health Manhiça (CISM) in the African country.

The survey results show that the efficacy of this vaccine is not as high as that of medicines for children but could save millions of lives affected by this disease transmitted by mosquitoes.